Delivery Order SPE2DR25D1109-SPE2DR26FFF6U
- Not listed
- The Defense Logistics Agency awarded a $4,719.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count packaging) with an ultimate completion date of November 14, 2025. This non-set-aside, competitively awarded contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Prevymis 480 mg tablets (7-count) with a ceiling value of $9,438.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication...
- The Defense Logistics Agency awarded a $9,438.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 480 mg tablets of Prevymis (a cytomegalovirus prophylaxis medication), with an ultimate completion date of October 20, 2025. This is a non-set-aside, competitively awarded contract executed on September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular focus on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract valued at $4,719.34, with completion scheduled for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract with a ceiling value of $4,719.34. The contract type is a delivery order with an ultimate completion date of October 7, 2025, and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging) with a ceiling value of $4,719.34. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for ultimate completion by August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This firm fixed-price delivery order, valued at $4,719.34, represents a non-competitive set-aside award and is scheduled for completion by May 15, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis (letermovir) is an antiviral...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract contains no set-aside designation and represents a competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF6UDelivery Order
The Defense Logistics Agency awarded a $4,973.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) on October 27, 2025, with completion targeted for November 18, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily for cytomegalovirus (CMV) prophylaxis in immunocompromised patients, commonly utilized within military and veteran healthcare systems. AmerisourceBergen's comprehensive IDC with DLA enables the company to serve as a prime pharmaceutical vendor globally, supplying a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other federal healthcare systems. The competitively awarded contract reflects AmerisourceBergen's established capability and market position as a critical pharmaceutical distributor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 10/27/25 |